Camargo, a division of Premier Research, is a leading global strategy, regulatory, and development partner for emerging to mid-size biopharma. We specialize in complex drug development programs where no playbook exists, with integrated solutions spanning from product concept to commercial stages that enable sponsors to reach milestones with speed and capital efficiency. We have experience in rare and accelerated approval pathways, specialty populations, and innovative science including orphan drugs, the 505(b)(2) pathway, oncology, neurology, pediatrics, combination products, and digital therapeutics. We are proud to support clients in more than 35 countries around the world.